Why Oric Pharmaceuticals ORIC might be early to something big Grinds Lower 20260506 What Regeneron Pharmaceuticals REGN does that its rivals cannot replicate Q1 2026 Better Than Expected What metric defines Valens Semiconductor VLN success this quarter Q4 2025 Profit Disappoints Korea KEP Growth Trajectory Korea posts 10 EPS miss amid cost pressures